• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MUELLER HINTON II AGAR; SEE H.10

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ MUELLER HINTON II AGAR; SEE H.10 Back to Search Results
Catalog Number 254081
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/14/2023
Event Type  malfunction  
Event Description
It was reported that while using the bd bbl¿ mueller hinton ii agar that there was contamination.The following information was provided by the initial reporter: arrived with contamination.
 
Manufacturer Narrative
There was another lot number reported to be involved.The information for that lot number is as follows: medical device lot #: 3024165, medical device expiration date: 2023-04-16, device manufacture date: 2023-01-24, common device name: culture media, antimicrobial susceptibility test, mueller hinton agar/broth.Initial reporter phone and address (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
H.6 investigation summary: complaint history review: the complaints trends were reviewed, and similar complaints was registered.However, no trend was identified.Batch history record (bhr) review: the batch history review did not indicate any discrepancies.All release testing was satisfactory, and no deviations were observed for both lot numbers.Sample analysis: the retain samples were reviewed and no deviation could be detected.Return samples were not provided; however, pictures sample were shared showing contaminated plates for both lot numbers.Evaluation results: at this stage of our investigation, we have excluded any systemic failure in our manufacturing process.This product does not have an sal (sterility assurance level) claim.It is filled aseptically; therefore, an occurrence of a contamination event cannot be entirely ruled out.Please note that the valid standard for these products is din en 12322 "in vitro diagnostic medical devices - culture media for microbiology".According to this standard the contamination rate for each product lot must not exceed 4.9%.Based upon our continuous monitoring, we derive a contamination rate that falls below this specified value.According to our high-quality standard, we only release product batches to the market with an aql (acceptable quality level) = 0,65.Although this contamination level is very low, we cannot completely exclude that a customer may receive contaminated plates.Investigation conclusion: based on the evaluation and the provided picture, the complaint was confirmed for contamination.A definite root cause could not be determined.Bd regrets the inconveniences you have experienced due to this issue and will continue monitoring incoming similar complaints.
 
Event Description
It was reported that while using the bd bbl¿ mueller hinton ii agar that there was contamination.The following information was provided by the initial reporter: arrived with contamination.Pictures attached.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ MUELLER HINTON II AGAR
Type of Device
SEE H.10
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key16588921
MDR Text Key312226985
Report Number1119779-2023-00310
Device Sequence Number1
Product Code JTZ
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
PREAMENDMENT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/26/2023
Device Catalogue Number254081
Device Lot Number3003058
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/14/2023
Initial Date FDA Received03/22/2023
Supplement Dates Manufacturer Received03/24/2023
Supplement Dates FDA Received03/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/03/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-